Pruritus was the principal adverse event ; incidence values in the OCA 10 mg , 25 mg , and 50 mg groups were 47 % ( not significantly different ) , 87 % ( P < .0003 ) , and 80 % ( P < .006 ) , respectively , vs 50 % in the placebo group .